Cargando…

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor

Among β-blockers that are clinically prescribed for heart failure, carvedilol is a first-choice agent with unique pharmacological properties. Carvedilol is distinct from other β-blockers in its ability to elicit β-arrestin–biased agonism, which has been suggested to underlie its cardioprotective eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pani, Biswaranjan, Ahn, Seungkirl, Rambarat, Paula K., Vege, Shashank, Kahsai, Alem W., Liu, Andrew, Valan, Bruno N., Staus, Dean P., Costa, Tommaso, Lefkowitz, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998675/ https://www.ncbi.nlm.nih.gov/pubmed/34580163 http://dx.doi.org/10.1124/molpharm.121.000363

Ejemplares similares

Small-Molecule Positive Allosteric Modulators of the β(2)-Adrenoceptor Isolated from DNA-Encoded Libraries
por: Ahn, Seungkirl, et al.
Publicado: (2018)

Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin
por: Kahsai, Alem W., et al.
Publicado: (2023)

Gα(i) is required for carvedilol-induced β(1) adrenergic receptor β-arrestin biased signaling
por: Wang, Jialu, et al.
Publicado: (2017)

The GPCR–β-arrestin complex allosterically activates C-Raf by binding its amino terminus
por: Zang, Yunxiang, et al.
Publicado: (2021)

Allosteric activation of proto-oncogene kinase Src by GPCR–beta-arrestin complexes
por: Pakharukova, Natalia, et al.
Publicado: (2021)

Conformationally Selective RNA Aptamers Allosterically Modulate the β(2)-Adrenoceptor
por: Kahsai, Alem W., et al.
Publicado: (2016)

How carvedilol does not activate β(2)-adrenoceptors
por: Lefkowitz, Robert J., et al.
Publicado: (2023)

Allosteric modulator potentiates β(2)AR agonist–promoted bronchoprotection in asthma models
por: Ahn, Seungkirl, et al.
Publicado: (2023)

β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
por: Ahn, Seungkirl, et al.
Publicado: (2009)

Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation
por: Staus, Dean P, et al.
Publicado: (2016)

β-arrestin 1 regulates β2-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility
por: Kim, Jihee, et al.
Publicado: (2018)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy
por: Hoare, Joseph I., et al.
Publicado: (2022)

Discovery of β2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor
por: Aristotelous, Tonia, et al.
Publicado: (2013)

Structure of the M2 muscarinic receptor-β-arrestin complex in a lipid nanodisc
por: Staus, Dean P., et al.
Publicado: (2020)

Arresting a Transient Receptor Potential (TRP) Channel: β-ARRESTIN 1 MEDIATES UBIQUITINATION AND FUNCTIONAL DOWN-REGULATION OF TRPV4
por: Shukla, Arun K., et al.
Publicado: (2010)

Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
por: Grisanti, Laurel A., et al.
Publicado: (2018)

Lipids and Phosphorylation Conjointly Modulate Complex Formation of β(2)-Adrenergic Receptor and β-arrestin2
por: Pluhackova, Kristyna, et al.
Publicado: (2021)

Independent β-Arrestin2 and G(q)/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
por: Kim, Jihee, et al.
Publicado: (2009)

Competing G protein-coupled receptor kinases balance G protein and β-arrestin signaling
por: Heitzler, Domitille, et al.
Publicado: (2012)

Mechanism of allosteric regulation of β(2)-adrenergic receptor by cholesterol
por: Manna, Moutusi, et al.
Publicado: (2016)

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors
por: Han, Sang-oh, et al.
Publicado: (2012)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020)

Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor
por: Weiss, Dahlia R., et al.
Publicado: (2013)

β-Arrestin–dependent activation of Ca(2+)/calmodulin kinase II after β(1)–adrenergic receptor stimulation
por: Mangmool, Supachoke, et al.
Publicado: (2010)

Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome
por: Wong, Wei-Ting, et al.
Publicado: (2018)

The β-Blocker Carvedilol Prevents Benzo(a)pyrene-Induced Lung Toxicity, Inflammation and Carcinogenesis
por: Shahid, Ayaz, et al.
Publicado: (2023)

Allosteric modulation of GPCR-induced β-arrestin trafficking and signaling by a synthetic intrabody
por: Baidya, Mithu, et al.
Publicado: (2022)

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
por: Boyhus, Lotte-Emilie, et al.
Publicado: (2018)

Structure of active β-arrestin1 bound to a G protein-coupled receptor phosphopeptide
por: Shukla, Arun K., et al.
Publicado: (2013)

Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex
por: Naga Prasad, Sathyamangla V., et al.
Publicado: (2002)

β-arrestin2 regulating β2-adrenergic receptor signaling in hepatic stellate cells contributes to hepatocellular carcinoma progression
por: Li, Xiu-Qin, et al.
Publicado: (2021)

β‐arrestin2 recruitment at the β2 adrenergic receptor: A luciferase complementation assay adapted for undergraduate training in pharmacology
por: Ferraiolo, Mattia, et al.
Publicado: (2021)

β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
por: Lashen, Sameh A, et al.
Publicado: (2022)

Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure
por: Hou, Dong-Yan, et al.
Publicado: (2020)

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
por: Rodriguiz, Ramona M., et al.
Publicado: (2021)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
por: Casabella-Ramón, Sergi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3in1435990ajau5d87qogripse